Waltham Latest News (Massachusetts, United States)

Integration of Nova's BioProfile® FLEX2 will enable automated cell culture analyses for process development through commercial manufacturing with Quantum Flex

Nova Biomedical today announced the availability of the Nova Primary™ glucose reference analyzer, filling the need left by the discontinued YSI 2300 STAT PLUS Glucose and L-Lactate analyzer (YSI, Inc., Yellow Springs, OH).

Nova Biomedical announces the U.S. launch of our New Generation StatStrip Glucose Hospital Meter System.

Biomedical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for a micro capillary sample mode on the Stat Profile Prime Plus® Critical Care analyzer.

Featuring five lessons, the new curriculum is designed to help students in grades 1–3 understand how artificial intelligence works and what its limitations are.

Rope-like bands of internal scar tissue that form in 70-90% of patients who undergo abdominal surgery have bedeviled patients and surgeons since medical literature history's recording of adhesions in 1836

LMTK3 as prognostic marker for ovarian cancer and TTX335o, award-winning drug candidate with tumor-killing activity, presented as game-changing treatment for women

Newest Division offers custom business technology solutions to organizations experiencing rapid change

Powered by 40+ educators and 225 KIBO robots, the community outreach program brings STEAM and coding to rural students and families at no cost

Nova Biomedical is pleased to announce the launch of BioProfile FAST CDV, a high-throughput, fully automated viable cell density and viability analyzer capable of producing results in under 70 seconds with just 100μL of sample volume.

The international STEAM collaboration will show students in both countries that 'you can be anything you want to be in this world'

The U.S. Food and Drug Administration (FDA) has cleared Nova Primary as a blood glucose reference analyzer.